Back to Search
Start Over
Evergreen Theragnostics opens CCK2-VIEW, a Phase II small cell lung cancer clinical trial, in the European Union
- Source :
- Plus Company Updates. October 21, 2024
- Publication Year :
- 2024
-
Abstract
- SPRINGFIELD, N.J.: Evergreen Theragnostics, Inc. has issued the following news release: Evergreen Theragnostics, Inc., a clinical-stage radiopharmaceutical company, focused on providing additional treatment options for cancer patients, is pleased to [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.813141740